SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019428
Filing Date
2024-05-15
Accepted
2024-05-15 06:45:57
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1569554
2 ex31-1.htm EX-31.1 19189
3 ex31-2.htm EX-31.2 19125
4 ex32-1.htm EX-32.1 11068
  Complete submission text file 0001493152-24-019428.txt   8223481

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20240331.xsd EX-101.SCH 58859
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evfm-20240331_cal.xml EX-101.CAL 63930
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20240331_def.xml EX-101.DEF 294157
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20240331_lab.xml EX-101.LAB 447137
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20240331_pre.xml EX-101.PRE 370128
77 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1466627
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36754 | Film No.: 24947051
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)